Previous Article | Next Article ![]()
Infect. Immun., 01 1998, 11-17, Vol 66, No. 1
M Theisen, S Soe, C Oeuvray, AW Thomas, J Vuust, S Danielsen, S Jepsen and P Druilhe
Monocyte-dependent as well as direct inhibitory effects of antimalarial
antibodies point toward antigens accessible at the time of merozoite
release as targets for biologically active antibodies capable of mediating
protection against Plasmodium falciparum. The glutamate-rich protein
(GLURP), being an antigen associated with mature schizont- infected
erythrocytes, was therefore the object of the present investigation, in
which we analyzed whether anti-GLURP antibodies can either interfere
directly with merozoite invasion or act indirectly by promoting a
monocyte-dependent growth inhibition, antibody-dependent cellular
inhibition. GLURP-specific human immunoglobulin G (IgG) antibodies, from
pooled IgG of healthy Liberian adults who were clinically immune to
malaria, were purified by affinity chromatography on columns containing R0
(N-terminal nonrepetitive region of GLURP) or R2 (C-terminal repetitive
region of GLURP) recombinant protein or synthetic peptides as ligands.
Analysis of the pattern of reactivity of highly purified anti-GLURP
antibodies led to the definition of at least four B-cell epitopes. One
epitope was specific for R0, two were specific for R2, and the fourth
displayed cross-reactivity between R0 and R2. None of the purified IgG
antibodies had direct invasion- inhibitory effects, even at high
concentrations. In contrast, when allowed to cooperate with monocytes, all
anti-GLURP IgG preparations mediated a strong monocyte-dependent parasite
growth inhibition in a dose-dependent manner.
Copyright © 1998, American Society for Microbiology
The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro
Department of Clinical Biochemistry, Statens Seruminstitut, Copenhagen S, Denmark.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|